MEIKLEJOHN PHARMACY LTD

Company Registration Number:
03622112 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

MEIKLEJOHN PHARMACY LTD

Contents of the Financial Statements

for the Period Ended 31 October 2024

Balance sheet
Notes

MEIKLEJOHN PHARMACY LTD

Balance sheet

As at 31 October 2024


Notes

2024

16 months to 31 October 2023


£

£
Fixed assets
Tangible assets: 3 655,044 673,869
Total fixed assets: 655,044 673,869
Current assets
Stocks: 63,185 66,696
Debtors:   308,418 378,893
Cash at bank and in hand: 2,185,636 1,846,650
Total current assets: 2,557,239 2,292,239
Creditors: amounts falling due within one year:   (1,085,003) (1,190,911)
Net current assets (liabilities): 1,472,236 1,101,328
Total assets less current liabilities: 2,127,280 1,775,197
Total net assets (liabilities): 2,127,280 1,775,197
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 2,127,180 1,775,097
Shareholders funds: 2,127,280 1,775,197

The notes form part of these financial statements

MEIKLEJOHN PHARMACY LTD

Balance sheet statements

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 May 2025
and signed on behalf of the board by:

Name: Mrs I PANCHAL
Status: Director

The notes form part of these financial statements

MEIKLEJOHN PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MEIKLEJOHN PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

2. Employees

2024 16 months to 31 October 2023
Average number of employees during the period 9 9

MEIKLEJOHN PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

3. Tangible Assets

Total
Cost £
At 01 November 2023 1,104,929
Additions 4,318
Disposals (11,199)
At 31 October 2024 1,098,048
Depreciation
At 01 November 2023 431,060
Charge for year 23,142
On disposals (11,198)
At 31 October 2024 443,004
Net book value
At 31 October 2024 655,044
At 31 October 2023 673,869